Alpine Global Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Alpine Global Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-89,450	Closed	-$10.3M	–	267
2023 Q3	$10.3M	Sell	89,450 -141,476	-61%	-$15.2M	2.39%	9
2023 Q2	$23.8M	Buy	230,926 +160,926	+230%	+$17M	6.54%	3
2023 Q1	$7.64M	Buy	70,000 +50,000	+250%	+$5.53M	2.97%	9
2022 Q4	$2.28M	Buy	+20,000	New	+$1.66M	0.76%	23
2021 Q1	–	Sell	-6,417	Closed	-$469K	–	429
2020 Q4	$469K	Buy	+6,417	New	+$477K	0.1%	109
2016 Q2	–	Sell	-39,446	Closed	-$654K	–	281
2016 Q1	$654K	Buy	+39,446	New	+$690K	0.15%	65
2015 Q3	–	Sell	-44,097	Closed	-$1.53M	–	994
2015 Q2	$1.53M	Buy	+44,097	New	+$1.35M	0.26%	64
2015 Q1	–	Sell	-10,920	Closed	-$141K	–	576
2014 Q4	$141K	Buy	+10,920	New	+$137K	0.03%	483

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Global Management's HZNP Position: Q4 2023 in Review

Alpine Global Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 89,450 shares — an estimated $10.3M sold.

Alpine Global Management first reported a position in HZNP in Q4 2014 and held it in 8 quarters. The position peaked at $23.8M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Alpine Global Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Alpine Global Management sold 89,450 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $10.3M.
Alpine Global Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 8 quarters.
Alpine Global Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $23.8M in Q2 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Alpine Global Management's 13F filing for Q4 2023, filed 12 Feb 2024.